Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

T. Tanvetyanon · SciRah

Researcher profile · Semantic Scholar

T. Tanvetyanon

Share profile

T. Tanvetyanon — researcher profile on SciRah

h-index: 41
Works: 237
Citations: 7,434

Most-cited papers

Non-Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.
D. Ettinger, D. Wood, D. Aisner, W. Akerley +38 more
2022The Journal of the National Comprehensive Cancer Network1,156 citations
Semantic Scholar
Non-Small Cell Lung Cancer, Version 4.2024.
Gregory Riely, Douglas E. Wood, D. Ettinger, D. Aisner +41 more
2024The Journal of the National Comprehensive Cancer Network655 citations
Semantic Scholar
NCCN Guidelines® Insights: Non-Small Cell Lung Cancer, Version 2.2023.
D. Ettinger, D. Wood, D. Aisner, W. Akerley +39 more
2023The Journal of the National Comprehensive Cancer Network478 citations Open access
Semantic Scholar
Tumor-infiltrating lymphocyte treatment for anti-PD-1 resistant metastatic lung cancer: a phase I trial
B. Creelan, chao wang, J. Teer, E. Toloza +22 more
2021Nature Medicine379 citations Open access
Semantic Scholar
Phase 1/1b study of pembrolizumab plus vorinostat in advanced/metastatic non-small cell lung cancer
J. Gray, A. Saltos, T. Tanvetyanon, E. Haura +13 more
2019Clinical Cancer Research102 citations Open access
Semantic Scholar
Randomized-controlled phase II trial of salvage chemotherapy after immunization with a TP53-transfected dendritic cell-based vaccine (Ad.p53-DC) in patients with recurrent small cell lung cancer
A. Chiappori, Charles C. Williams, J. Gray, T. Tanvetyanon +8 more
2018Cancer Immunology and Immunotherapy63 citations Open access
Semantic Scholar
PD-1 checkpoint blockade alone or combined PD-1 and CTLA-4 blockade as immunotherapy for lung cancer?
T. Tanvetyanon, J. Gray, S. Antonia
2017Expert Opinion on Biological Therapy60 citations
Semantic Scholar
Non – Small Cell Lung Cancer, Version 3.2022
D. Ettinger, D. Wood, D. Aisner, W. Akerley +39 more
202257 citations
Semantic Scholar
Smoking Cessation, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.
P. Shields, L. Bierut, D. Arenberg, David Balis +27 more
2023The Journal of the National Comprehensive Cancer Network54 citations Open access
Semantic Scholar
Phase I study of taminadenant (PBF509/NIR178), an adenosine 2A receptor antagonist, with or without spartalizumab, in patients with advanced non-small cell lung cancer
A. Chiappori, B. Creelan, T. Tanvetyanon, J. Gray +14 more
2022Clinical Cancer Research50 citations Open access
Semantic Scholar
Safety, pharmacokinetics, and pharmacodynamics of oral omaveloxolone (RTA 408), a synthetic triterpenoid, in a first-in-human trial of patients with advanced solid tumors
B. Creelan, D. Gabrilovich, J. Gray, Charles C. Williams +11 more
2017OncoTargets and Therapy49 citations Open access
Semantic Scholar
Loneliness as a mediator of the relationship of social cognitive variables with depressive symptoms and quality of life in lung cancer patients beginning treatment
K. Hyland, B. Small, J. Gray, A. Chiappori +6 more
2019Psycho-Oncology48 citations
Semantic Scholar
Relationship Between Programmed Death Receptor-Ligand 1 Expression and Response to Checkpoint Inhibitor Immunotherapy in Pulmonary Sarcomatoid Carcinoma: A Pooled Analysis.
N. Babacan, I. B. Piña, D. Signorelli, A. Prelaj +2 more
2020Clinical Lung Cancer46 citations Open access
Semantic Scholar
Prospective Single-Arm Phase 1 and 2 Study: Ipilimumab and Nivolumab With Thoracic Radiation Therapy After Platinum Chemotherapy in Extensive-Stage Small Cell Lung Cancer
B. Perez, Sungjune Kim, Min-Hsuan Wang, A. Karimi +21 more
2020International Journal of Radiation Oncology, Biology, Physics43 citations Open access
Semantic Scholar
Phase I/II study of the A2AR antagonist NIR178 (PBF-509), an oral immunotherapy, in patients (pts) with advanced NSCLC.
A. Chiappori, Charles C. Williams, B. Creelan, T. Tanvetyanon +13 more
201842 citations
Semantic Scholar
A phase I/randomized phase II study of GM.CD40L vaccine in combination with CCL21 in patients with advanced lung adenocarcinoma
J. Gray, A. Chiappori, Charles C. Williams, T. Tanvetyanon +14 more
2018Cancer Immunology and Immunotherapy35 citations Open access
Semantic Scholar
Mesothelioma: Peritoneal, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology.
D. Ettinger, Douglas E. Wood, J. Stevenson, D. Aisner +39 more
2023The Journal of the National Comprehensive Cancer Network29 citations Open access
Semantic Scholar
Mesothelioma: Pleural, Version 1.2024.
J. Stevenson, D. Ettinger, Douglas E. Wood, D. Aisner +41 more
2024The Journal of the National Comprehensive Cancer Network27 citations Open access
Semantic Scholar
Phase 1 trial of dasatinib combined with afatinib for epidermal growth factor receptor- (EGFR-) mutated lung cancer with acquired tyrosine kinase inhibitor (TKI) resistance
B. Creelan, J. Gray, T. Tanvetyanon, A. Chiappori +4 more
2019British Journal of Cancer25 citations Open access
Semantic Scholar
Immunotherapy alone or chemo-immunotherapy as front-line treatment for advanced non-small cell lung cancer
M. Shafique, T. Tanvetyanon
2019Expert Opinion on Biological Therapy24 citations
Semantic Scholar
Preoperative nutrition-enhanced recovery after surgery protocol for thoracic neoplasms.
L. Robinson, T. Tanvetyanon, D. Grubbs, Noah A Robinson +4 more
2020Journal of Thoracic and Cardiovascular Surgery22 citations Open access
Semantic Scholar
Results of treating primary pulmonary sarcomas and pulmonary carcinosarcomas.
L. Robinson, N. Babacan, T. Tanvetyanon, E. Henderson-Jackson +2 more
2020Journal of Thoracic and Cardiovascular Surgery22 citations Open access
Semantic Scholar
Superimposed Clostridium difficile Infection During Checkpoint Inhibitor Immunotherapy-induced Colitis.
N. Babacan, T. Tanvetyanon
2019Journal of immunotherapy19 citations Open access
Semantic Scholar
Abstract CT056: Durable complete responses to adoptive cell transfer using tumor infiltrating lymphocytes (TIL) in non-small cell lung cancer (NSCLC): A phase I trial
B. Creelan, chao wang, J. Teer, E. Toloza +17 more
2020Tumor Biology18 citations
Semantic Scholar
Ipilimumab/Nivolumab-related Opsoclonus-Myoclonus-Ataxia Syndrome Variant in a Patient with Malignant Pleural Mesothelioma
B. Maller, E. Peguero, T. Tanvetyanon
2018Journal of immunotherapy16 citations
Semantic Scholar
Complete Tumor Response of Tracheal Squamous Cell Carcinoma After Treatment With Pembrolizumab.
B. Maller, F. Kaszuba, T. Tanvetyanon
2019Annals of Thoracic Surgery15 citations Open access
Semantic Scholar
Dose-Limiting Pulmonary Toxicity in a Phase 1/2 Study of Radiation and Chemotherapy with Ipilimumab Followed by Nivolumab for Patients With Stage 3 Unresectable Non-Small Cell Lung Cancer
C. Liveringhouse, K. Latifi, Amalin Asous, Nghi B. Lam +21 more
2023International Journal of Radiation Oncology, Biology, Physics14 citations
Semantic Scholar
A phase II single-arm study of CRS-207 with pembrolizumab (pembro) in previously treated malignant pleural mesothelioma (MPM).
E. Alley, T. Tanvetyanon, T. Jahan, L. Gandhi +7 more
2019Journal of Clinical Oncology13 citations
Semantic Scholar
Induction chemoradiotherapy versus chemotherapy alone for superior sulcus lung cancer.
L. Robinson, T. Tanvetyanon, D. Grubbs, S. Antonia +8 more
2018Lung Cancer12 citations
Semantic Scholar
Outcomes of Intraocular Metastasis From Lung Cancer in the Era of Targeted Therapy: A Systematic Review and Pooled Analysis.
B. Maller, Sarah Salvatori, T. Tanvetyanon
2022Clinical Lung Cancer11 citations
Semantic Scholar
Immune-Related Toxicity Among Adolescent and Young Adult with Melanoma as Compared with the Elderly
Alicia Darwin, Amber M Skinner, D. Reed, T. Tanvetyanon
2022Journal of Adolescent and Young Adult Oncology11 citations
Semantic Scholar
Phase II randomized trial of first-line pembrolizumab and vorinostat in patients with metastatic NSCLC (mNSCLC).
A. Saltos, T. Tanvetyanon, B. Creelan, M. Shafique +12 more
202011 citations
Semantic Scholar
P1.04-32 Phase I/II Study of the A2AR Antagonist NIR178 (PBF-509), an Oral Immunotherapy, in Patients (pts) with Advanced NSCLC
A. Chiappori, Charles C. Williams, B. Creelan, T. Tanvetyanon +13 more
2018Journal of Thoracic Oncology10 citations Open access
Semantic Scholar
Combination chemotherapy and immunotherapy in metastatic non-small cell lung cancer: a setback for personalized medicine?
Monica S Chatwal, T. Tanvetyanon
2018Translational Lung Cancer Research9 citations Open access
Semantic Scholar
OA05.03 Safety and Clinical Activity of Adoptive Cell Transfer Using Tumor Infiltrating Lymphocytes (TIL) Combined with Nivolumab in NSCLC
B. Creelan, J. Teer, E. Toloza, J. Mullinax +12 more
2018Journal of Thoracic Oncology9 citations Open access
Semantic Scholar
Effect of advanced age on peri-operative outcomes after robotic-assisted pulmonary lobectomy: Retrospective analysis of 287 consecutive cases.
Kathryn Kass, F. Velez-Cubian, Wei-Wen Zhang, Kavian Toosi +7 more
2017Journal of Geriatric Oncology9 citations
Semantic Scholar
Phase II randomized trial of first-line pembrolizumab and vorinostat in patients with metastatic NSCLC (mNSCLC): Final results.
A. Saltos, T. Tanvetyanon, B. Creelan, M. Shafique +11 more
2023Journal of Clinical Oncology8 citations
Semantic Scholar
A Prospective Single Arm Phase I/II Study: Consolidative Ipilimumab and Nivolumab with Thoracic Radiotherapy after Platinum Based Chemotherapy for Patients with Extensive-Stage Small Cell Lung Cancer
B. Perez, S.-W. Kim, T. Dilling, K. Latifi +14 more
2019International Journal of Radiation Oncology, Biology, Physics8 citations Open access
Semantic Scholar
Malignant mesothelioma clinical trial combines immunotherapy drugs.
Monica S Chatwal, T. Tanvetyanon
2018Immunotherapy8 citations Open access
Semantic Scholar
Epigenetic modulation of immunotherapy cofactors to enhance tumor response in lung cancer
A. Kommalapati, T. Tanvetyanon
2020Human Vaccines & Immunotherapeutics7 citations Open access
Semantic Scholar
Phase I/Ib study of pembrolizumab and vorinostat in patients with metastatic NSCLC (mNSCLC).
A. Saltos, T. Tanvetyanon, Charles C. Williams, E. Haura +9 more
20187 citations
Semantic Scholar
Abstract CT052: A phase IB study of mRNA-based active cancer vaccine, BI1361849, combined with durvalumab and tremelimumab immunotherapy in patients with non-small cell lung cancer (NSCLC)
Dung-Tsa Chen, Joshua Sabari, J. Thompson, J. Niu +10 more
2024Cancer Research6 citations
Semantic Scholar
Surgery and Stereotactic Radiotherapy for Stage I Small-Cell Lung Carcinoma: A 25-Year Experience.
Lary A. Robinson, T. Tanvetyanon, Noah A Robinson, Sandra Bryant +3 more
2024Clinical Lung Cancer5 citations Open access
Semantic Scholar
A phase I/IB trial of binimetinib in combination with erlotinib in NSCLC harboring activating KRAS or EGFR mutations.
A. Saltos, B. Creelan, T. Tanvetyanon, A. Chiappori +10 more
2023Lung Cancer5 citations
Semantic Scholar
Timeliness of EGFR/ALK Inhibitor Treatment and Survival in Lung Cancer: A Population-Based Analysis.
T. Tanvetyanon, Dung-Tsa Chen, J. Gray
2024Clinical Lung Cancer4 citations
Semantic Scholar
Fatal Tracheoesophageal Puncture Leakage Associated With Lenvatinib
Sarah Salvatori, T. Tanvetyanon
2023Cureus4 citations Open access
Semantic Scholar
Frontline pembrolizumab for the treatment of RET-rearranged non-small cell lung cancer: A case report.
Sheon Baby, F. Khalil, T. Tanvetyanon
2021Cancer Treatment and Research Communications4 citations Open access
Semantic Scholar
Efficacy of tyrosine kinase inhibitors against lung cancer with EGFR exon 18 deletion: Case report and pooled analysis.
Rafael Rubiera-Pebe, J. K. Hicks, T. Tanvetyanon
2021Cancer Treatment and Research Communications4 citations Open access
Semantic Scholar
MA13.02 Phase II Study of Nivolumab and Ipilimumab Combined With Nintedanib in Recurrent Non-Small Cell Lung Cancer
S. Puri, T. Tanvetyanon, B. Creelan, M. Shafique +7 more
2021Journal of Thoracic Oncology4 citations Open access
Semantic Scholar
Characteristics and Outcomes of Lung Cancer Screening Among Individuals With or Without Cancer History.
B. Maller, V. Simmons, M. Byrne, T. Tanvetyanon
2020Clinical Lung Cancer4 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

B. Creelan×21
Invite
B. Creelan — researcher profile on SciRah
J. Gray×20
Invite
J. Gray — researcher profile on SciRah
E. Haura×19
Invite
E. Haura — researcher profile on SciRah
A. Chiappori×14
Invite
A. Chiappori — researcher profile on SciRah

×14

Invite

S. Antonia — researcher profile on SciRah

Dung-Tsa Chen×12

Invite

Dung-Tsa Chen — researcher profile on SciRah

Invite

A. Saltos — researcher profile on SciRah

Invite

T. Dilling — researcher profile on SciRah

Invite

M. Shafique — researcher profile on SciRah

Invite

R. Thapa — researcher profile on SciRah

Invite

T. Boyle — researcher profile on SciRah

Invite

A. Beg — researcher profile on SciRah